Effect of Congo red on wild-type and mutated prion proteins in cultured cells

Journal of Neurochemistry

Volumn 74, Issue 1, 2000, Pages 222-230

  Milhavet, Ollivier ^a   Mangé, Alain ^a   Casanova, Danielle ^a   Lehmann, Sylvain ^a  

^a INSTITUTE OF HUMAN GENETICS   (France)

Author keywords

Congo red; Prion protein; Transmissible spongiform encephalopathies

Indexed keywords

CONGO RED; GLYCOSAMINOGLYCAN; PRION PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHO CELL; CONTROLLED STUDY; DRUG MECHANISM; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN SYNTHESIS; SOLUBILITY;

ANIMALS; CELL MEMBRANE; CHO CELLS; CONGO RED; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; ENDOPEPTIDASE K; MICE; MUTATION; PRIONS; SOLUBILITY; TIME FACTORS;

ANIMALIA;

EID: 0033961817     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0740222.x     Document Type: Article

References (48)

1. Bessen R. A. and Marsh R. F. (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68, 7859-7868.
2. Borchelt D. R., Taraboulos A., and Prusiner S. B. (1992) Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem. 267, 16188-16199.
3. Bordier C. (1981) Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256, 1604-1607.
4. Bueler H., Aguzzi A., Sailer A., Greiner R. A., Autenried P., Aguet M., and Weissmann C. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347.
5. Caspi S., Halimi M., Yanai A., Sasson S. B., Taraboulos A., and Gabizon R. (1998) The anti-prion activity of Congo red. Putative mechanism. J. Biol. Chem. 273, 3484-3489.
6. Caughey B. and Race R. E. (1992) Potent inhibition of scrapie-associated PrP accumulation by Congo red. J. Neurochem. 59, 768-771.
7. Caughey B. and Raymond G. J. (1993) Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J. Virol. 67, 643-650.
8. Caughey B., Raymond G. J., Ernst D., and Race R. E. (1991a) N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J. Virol. 65, 6597-6603.
9. Caughey B. W., Dong A., Bhat K. S., Ernst D., Hayes S. F., and Caughey W. S. (1991b) Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30, 7672-7680.
10. Caughey B., Brown K., Raymond G. J., Katzenstein G. E., and Thresher W. (1994) Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and Congo red. J. Virol. 68, 2135-2141.
11. Caughey B., Kocisko D. A., Raymond G. J., and Lansbury P. T. Jr. (1995) Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem. Biol. 2, 807-817.
12. Chiesa R., Piccardo P., Ghetti B., and Harris D. A. (1998) Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21, 1339-1351.
13. Daude N., Lehmann S., and Harris D. A. (1997) Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells. J. Biol. Chem. 272, 11604-11612.
14. Demaimay R., Harper J., Gordon H., Weaver D., Chesebro B., and Caughey B. (1998) Structural aspects of Congo red as an inhibitor of protease-resistant prion protein formation. J. Neurochem. 71, 2534-2541.
15. Demaimay R., Race R., and Chesebro B. (1999) Effectiveness of polyene antibiotics in treatment of transmissible spongiform encephalopathy in transgenic mice expressing Syrian hamster PrP only in neurons. J. Virol. 73, 3511-3513.
16. Edenhofer F., Rieger R., Famulok M., Wendler W., Weiss S., and Winnacker E. L. (1996) Prion protein Prpc interacts with molecular chaperones of the Hsp60 family. J. Virol. 70, 4724-4728.
17. Ehlers B. and Diringer H. (1984) Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. J. Gen. Virol. 65, 1325-1330.
18. Farquhar C. F. and Dickinson A. G. (1986) Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection. J. Gen. Virol. 67, 463-473.
19. Gasset M., Baldwin M. A., Lloyd D. H., Gabriel J. M., Holtzman D. M., Cohen F., Fletterick R., and Prusiner S. B. (1992) Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid. Proc. Natl. Acad. Sci. USA 89, 10940-10944.
20. Grassi J., Frobert Y., Lamourette P., and Lagoutte B. (1988) Screening of monoclonal antibodies using antigens labeled with acetylcholinesterase: application to the peripheral proteins of photosystem 1. Anal. Biochem. 168, 436-450.
21. Ingrosso L., Ladogana A., and Pocchiari M. (1995) Congo red prolongs the incubation period in scrapie-infected hamsters. J. Virol. 69, 506-508.
22. Jackson G. S., Hosszu L. L., Power A., Hill A. F., Kenney J., Saibil H., Craven C. J., Waltho J. P., Clarke A. R., and Collinge J. (1999) Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283, 1935-1937.
23. Kascsak R. J., Rubinstein R., Merz P. A., Tonna-DeMasi M., Fersko R., Carp R. I., Wisniewski H. M., and Diringer H. (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61, 3688-3693.
24. Kimberlin R. H. and Walker C. A. (1986) Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions. Antimicrob. Agents Chemother. 30, 409-413.
25. Kocisko D. A., Come J. H., Priola S. A., Chesebro B., Raymond G. J., Lansbury P. T., and Caughey B. (1994) Cell-free formation of protease-resistant prion protein. Nature 370, 471-474.
26. Lasmezas C. I., Deslys J. P., Robain O., Jaegly A., Beringue V., Peyrin J. M., Fournier J. G., Hauw J. J., Rossier J., and Dormont D. (1997) Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275, 402-405.
27. Lehmann S. and Harris D. A. (1995) A mutant prion protein displays an aberrant membrane association when expressed in cultured cells. J. Biol. Chem. 270, 24589-24597.
28. Lehmann S. and Harris D. A. (1996) Mutant and infectious prion proteins display common biochemical properties in cultured cells. J. Biol. Chem. 271, 1633-1637.
29. Lehmann S. and Harris D. A. (1997) Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J. Biol. Chem. 272, 21479-21487.
30. Martins V. R., Graner E., Garcia-Abreu J., de Souza S. J., Mercadante A. F., Veiga S. S., Zanata S. M., Neto V. M., and Brentani R. R. (1997) Complementary hydropathy identifies a cellular prion protein receptor. Nat. Med. 3, 1376-1382.
31. Pan K. M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R. J., Cohen F. E., et al. (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90, 10962-10966.
32. Parchi P. and Gambetti P. (1995) Human prion diseases. Curr. Opin. Neurol. 8, 286-293.
33. Pauly P. C. and Harris D. A. (1998) Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273, 33107-33110.
34. Pocchiari M. (1994) Prions and related neurological diseases. Mol. Aspects Med. 15, 195-291.
35. Pocchiari M., Salvatore M., Ladogana A., Ingrosso L., Xi Y. G., Cibati M., and Masullo C. (1991) Experimental drug treatment of scrapie: a pathogenetic basis for rationale therapeutics. Eur. J. Epidemiol. 7, 556-561.
36. Priola S. A. and Caughey B. (1994) Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis. Mol. Neurobiol. 8, 113-120.
37. Prusiner S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144.
38. Prusiner S. B., Groth D. F., Bolton D. C., Kent S. B., and Hood L. E. (1984) Purification and structural studies of a major scrapie prion protein. Cell 38, 127-134.
39. Prusiner S. B., Scott M., Foster D., Pan K. M., Groth D., Mirenda C., Torchia M., Yang S. L., Serban D., and Carlson G. A. (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63, 673-686.
40. Prusiner S. B., Scott M. R., De Armond S. J., and Cohen F. E. (1998) Prion protein biology. Cell 93, 337-348.
41. Rieger R., Edenhofer F., Lasmezas C. I., and Weiss S. (1997) The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat. Med. 3, 1383-1388.
42. Shyng S. L., Lehmann S., Moulder K. L., and Harris D. A. (1995a) Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. J. Biol. Chem. 270, 30221-30229.
43. Shyng S. L., Moulder K. L., Lesko A., and Harris D. A. (1995b) The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin-coated pits. J. Biol. Chem. 270, 14793-14800.
44. Snow A. D., Wight T. N., Nochlin D., Koike Y., Kimata K., DeArmond S. J., and Prusiner S. B. (1990) Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. Lab. Invest. 63, 601-611.
45. Tagliavini F., McArthur R. A., Canciani B., Giaccone G., Porro M., Bugiani M., Lievens P. M., Bugiani O., Peri E., Dall'Ara P., Rocchi M., Poli G., Forloni G., Bandiera T., Varasi M., Suarato A., Cassutti P., Cervini M. A., Lansen J., Salmona M., and Post C. (1997) Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science 276, 1119-1122.
46. Taraboulos A., Raeber A. J., Borchelt D. R., Serban D., and Prusiner S. B. (1992) Synthesis and trafficking of prion proteins in cultured cells. Mol. Biol. Cell 3, 851-863.
47. Telling G. C., Scott M., Mastriani J., Gabizon R., Torchia M., Cohen F. E., DeArmond S. J., and Prusiner S. B. (1995) Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83, 79-90.
48. Vey M., Pilkuhn S., Wille H., Nixon R., DeArmond S. J., Smart E. J., Anderson R. G., Taraboulos A., and Prusiner S. B. (1996) Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc. Natl. Acad. Sci. USA 93, 14945-14949.